Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Merck Serono and BMS Team Up to Offer Diabetes Drug to China

publication date: Mar 20, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Merck Serono, a division of Merck KGaA, will collaborate with Bristol-Myers Squibb to promote China distribution of Glucophage®, the type 2 diabetes treatment known generically as metformin. Merck Serono discovered metformin in 1957. However, Bristol-Myers Squibb-SASS has been distributing the immediate-release formulation of the drug in China since 1999. The two companies will also introduce newer formulations of the drug to China. More details....

Stock Symbols: (F: MRK) (NYSE: BMY)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners